Jinhai Medical Posts H1 2024 Loss Amid Rising Costs

Jinhai International Group Holdings Limited (HK:2225) has released an update.

Jinhai Medical Technology Limited, previously known as Jinhai International Group Holdings Limited, has reported a significant loss for the first half of 2024. The company experienced a swing from a modest profit in the same period last year to a substantial loss, despite an increase in revenue. This downturn was attributed to higher costs of sales and services, increased administrative expenses, and finance costs, resulting in a total comprehensive expense for the period.

For further insights into HK:2225 stock, check out TipRanks’ Stock Analysis page.